Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center AnalysisSigrid Machherndl‐Spandl, Veronika Buxhofer‐Ausch, Gerald Webersinke et al.|Cancers|2024Cited by 4